1. Department of Infection, Immunity, and Cardiovascular Disease and
2. Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom;
3. Medical Research Council/University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom;
4. Laboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Center, VIB, Leuven, Belgium;
5. Department of Oncology, KU Leuven, Leuven, Belgium; and
6. School of Medicine, University of Manchester, Manchester, United Kingdom